No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: No differences in survival in patients with esophageal cancer treated with neoadjuvant chemotherapy or chemoradiotherapy followed by esophagectomy

byTeddy Guo

April 22, 2021

in StudyGraphics

Reading Time: 1 min read

Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation

RelatedReports

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Chronic Disease

Active surveillance is cost-effective compared with standard surgery among esophageal cancer patients with complete clinical response after neoadjuvant chemoradiotherapy

August 6, 2026

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

Chronic Disease

Septoplasty is more costly but more effective than medical management for deviated septum

July 13, 2026

Development of a risk index for colorectal cancer screening

Chronic Disease

Neoadjuvant chemotherapy does not improve disease-free survival in patients with locally advanced colon cancer

March 25, 2026

Chronic Disease

Camrelizumab may be safe and effective in the management of locally advanced esophageal squamous cell carcinoma

March 19, 2026

Combined MRI and NIH stroke scores may predict stroke prognosis

Levetiracetam not clinically effective nor cost-effective compared to valproate for newly diagnosed generalized or unclassified epilepsy

Physical therapy reduces pain in adults with knee osteoarthritis

Web-based intervention of self-directed strengthening exercises improved pain and functional capacity for patients with osteoarthritis

#VisualAbstract Ivosidenib or enasidenib combined with intensive chemotherapy were well-tolerated and showed encouraging clinical activity in newly diagnosed mIDH1/mIDH2 acute myeloid leukemia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: No differences in survival in patients with esophageal cancer treated with neoadjuvant chemotherapy or chemoradiotherapy followed by esophagectomy

RELATED REPORTS

Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation

Levetiracetam not clinically effective nor cost-effective compared to valproate for newly diagnosed generalized or unclassified epilepsy

RelatedReports

Recent Reports